• Biosynex exited court protection after the Strasbourg Judicial Court confirmed its safeguard plan on Oct. 12, 2026.
• The plan binds all affected parties, including dissenting creditors.
• Execution could cut principal liabilities by EUR 20.1 million via unsecured creditor debt waivers, subject to final claims admission.
• The plan also предусматриes a waiver of accrued or future interest on bank borrowings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biosynex SA published the original content used to generate this news brief via EQS News (Ref. ID: fr_reg_2414324_fr) on October 12, 2026, and is solely responsible for the information contained therein.